{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:13:42Z","timestamp":1784546022970,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA233576"],"award-info":[{"award-number":["CA233576"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ACB-12002"],"award-info":[{"award-number":["ACB-12002"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["W-31-109-Eng-38"],"award-info":[{"award-number":["W-31-109-Eng-38"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["AGM-12006"],"award-info":[{"award-number":["AGM-12006"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM138396"],"award-info":[{"award-number":["P30GM138396"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.str.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T10:47:55Z","timestamp":1663325275000},"page":"1508-1517.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase, Fgr"],"prefix":"10.1016","volume":"30","author":[{"given":"Shoucheng","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Wales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie A.","family":"Moroco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Engen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-3806","authenticated-orcid":false,"given":"Thomas E.","family":"Smithgall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2022.08.008_bib1","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1073\/pnas.1819825116","article-title":"Gain-of-function mutations in a member of the Src family kinases cause autoinflammatory bone disease in mice and humans","volume":"116","author":"Abe","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2022.08.008_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib3","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0960-894X(00)00441-8","article-title":"Pyrrolo[2, 3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I","volume":"10","author":"Arnold","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.str.2022.08.008_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/acschembio.9b00214","article-title":"Targeting dynamic ATP-binding site features allows discrimination between highly homologous protein kinases","volume":"14","author":"Chakraborty","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.str.2022.08.008_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2005.07.027","article-title":"Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases","volume":"1754","author":"Chong","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.str.2022.08.008_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-021-04263-y","article-title":"Behavioural immune landscapes of inflammation","volume":"601","author":"Crainiciuc","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.str.2022.08.008_bib7","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood-2012-11-466425","article-title":"The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents","volume":"122","author":"Dos Santos","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.str.2022.08.008_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib9","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1007\/s00018-008-8122-2","article-title":"Structure and dynamic regulation of Src-family kinases","volume":"65","author":"Engen","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.str.2022.08.008_bib10","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1016\/S0021-9258(19)39058-1","article-title":"Purification and enzymatic characterization of pp60c-src from human platelets","volume":"265","author":"Feder","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2022.08.008_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.str.2017.07.014","article-title":"Achieving a graded immune response: BTK adopts a range of active\/inactive conformations dictated by multiple interdomain contacts","volume":"25","author":"Joseph","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.str.2022.08.008_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","article-title":"Src kinases as therapeutic targets for cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.str.2022.08.008_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428194.2014.907897","article-title":"Src family kinases and their role in hematological malignancies","volume":"56","author":"Ku","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.str.2022.08.008_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"Procheck - a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C-alpha geometry: phi, psi and C-beta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.str.2022.08.008_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","article-title":"Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments","volume":"16","author":"Masson","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.str.2022.08.008_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib19","doi-asserted-by":"crossref","first-page":"e105629","DOI":"10.1371\/journal.pone.0105629","article-title":"Differential sensitivity of Src-family kinases to activation by SH3 domain displacement","volume":"9","author":"Moroco","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2022.08.008_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nchembio.1938","article-title":"The ins and outs of selective kinase inhibitor development","volume":"11","author":"M\u00fcller","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.str.2022.08.008_bib21","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1074\/jbc.R112.438382","article-title":"Structure and dynamic regulation of Abl kinases","volume":"288","author":"Panjarian","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2022.08.008_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1107\/S1399004713028654","article-title":"Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002","volume":"70","author":"Parker","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2022.08.008_bib23","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acschembio.0c00373","article-title":"In\u00a0vitro evolution reveals a single mutation as sole Source of src-family kinase C-Helix-out inhibitor resistance","volume":"15","author":"Patel","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.str.2022.08.008_bib24","doi-asserted-by":"crossref","first-page":"e0225887","DOI":"10.1371\/journal.pone.0225887","article-title":"Expression of myeloid Src-family kinases is associated with poor prognosis in AML and influences Flt3-ITD kinase inhibitor acquired resistance","volume":"14","author":"Patel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2022.08.008_bib25","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.str.2022.08.008_bib26","doi-asserted-by":"crossref","first-page":"181ra52","DOI":"10.1126\/scitranslmed.3004387","article-title":"A pyrrolo-pyrimidine derivative targets human primary AML stem cells in\u00a0vivo","volume":"5","author":"Saito","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.str.2022.08.008_bib27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.str.2022.08.008_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(00)80357-3","article-title":"Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor","volume":"3","author":"Schindler","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2022.08.008_bib29","doi-asserted-by":"crossref","first-page":"eaat5916","DOI":"10.1126\/scisignal.aat5916","article-title":"The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation","volume":"11","author":"Shen","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.str.2022.08.008_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/385602a0","article-title":"Crystal structure of the Src family tyrosine kinase Hck","volume":"385","author":"Sicheri","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.str.2022.08.008_bib31","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1021\/ac8008862","article-title":"High-speed and high-resolution UPLC separation at zero degrees Celsius","volume":"80","author":"Wales","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.str.2022.08.008_bib32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1021\/acschembio.8b00154","article-title":"Selective inhibition of the myeloid Src-family kinase Fgr potently suppresses AML cell growth in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Weir","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.str.2022.08.008_bib33","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1038\/sj.onc.1206008","article-title":"Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis","volume":"21","author":"Wilson","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.str.2022.08.008_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.str.2022.08.008_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1097-2765(00)80356-1","article-title":"Crystal structures of c-Src reveal features of its autoinhibitory mechanism","volume":"3","author":"Xu","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2022.08.008_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/385595a0","article-title":"Three-dimensional structure of the tyrosine kinase c-Src","volume":"385","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.str.2022.08.008_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tips.2011.11.002","article-title":"Targeting Src family kinases in anti-cancer therapies: turning promise into triumph","volume":"33","author":"Zhang","year":"2012","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212622003525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212622003525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:41:41Z","timestamp":1778575301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212622003525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0969212622003525"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2022.08.008","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP-site inhibitors induce unique conformations of the acute myeloid leukemia-associated Src-family kinase, Fgr","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}